Integrated provider of drug discovery, development, and manufacturing services to leverage SIGNET’s pharma services expertise for…
Continue ReadingAutor: Press Room Team
USound Reveals High-performing ASIC Linear Audio Amplifier to Boost the Battery Life of TWS, Hearing Aids, and Smart Glasses
The new ASIC linear audio amplifier for USound MEMS speakers exceeds market demands by reaching 0.9…
Continue Reading
Asante Capital Group Strengthens Strategic Focus in Asia
Strong Talent and Continued Investment in Hong Kong Office Enhance Asian GPs’ Connections with Global Capital…
Continue Reading
Sidra Capital Announces the First Close of an Asia-Pacific Private Equity Co-Investment Strategy With BlackRock Alternatives
JEDDAH, Saudi Arabia–(BUSINESS WIRE)–Sidra Capital, the Saudi based alternative asset manager, partners with BlackRock Alternatives to…
Continue Reading
More Than 350 Latin American Doctors Take Part in the Region’s Second Ferrer Summit
The second LatAm Ferrer Summit, held in Panama, offered specialists an overview of the latest advances…
Continue Reading
Biotechs, Developing Countries Vaccine Manufacturers and Pharma Unite Behind a Proposal to G20 and G7 Offering a Practical Solution for Better Access to Vaccines for Future Pandemics
The vaccines innovators and manufacturers who have produced over 15 billion COVID-19 vaccines to date are…
Continue Reading
‘Greediad!’ – AHF Advocates Hammer Gilead with Weeklong Protests
Twice-daily Protests at Company’s Foster City HQ—Oct. 24-Oct. 28 Advocates to protest Gilead’s drug pricing and…
Continue Reading
Tigo Energy Helps Solar Installer Achieve Australian Safety Standards at Mining Sites with Rapid Shutdown Technology
Tigo will present the growing trend of rapid shutdown requirements worldwide at All-Energy Australia Exhibition and…
Continue Reading
Mevion Identifies Site for New Compact Proton Therapy System in Development
The MEVION S250-FIT would be the first and only proton therapy system that can be installed…
Continue Reading
Merck’s PREVYMIS™ Demonstrates Efficacy in Phase 3 Study for Prevention of Cytomegalovirus Disease in Adults After Kidney Transplantation
PREVYMIS showed non-inferior efficacy and more favorable safety profile compared to standard of care; results presented…
Continue Reading